Regioselective synthesis, antimicrobial evaluation and theoretical studies of 2-styryl quinolines

被引:81
作者
Kamal, Ahmed [1 ]
Rahim, Abdul [1 ]
Riyaz, Sd [1 ]
Poornachandra, Y. [1 ]
Balakrishna, Moku [1 ]
Kumar, C. Ganesh [1 ]
Hussaini, Syed Mohammed Ali [1 ]
Sridhar, B. [2 ]
Machiraju, Pavan Kumar [3 ]
机构
[1] CSIR Indian Inst Chem Technol, Hyderabad 500007, Andhra Pradesh, India
[2] CSIR Indian Inst Chem Technol, Div Xray Crystallog, Hyderabad 500007, Andhra Pradesh, India
[3] GVK Biosci Pvt Ltd, Hyderabad 500076, Andhra Pradesh, India
关键词
MYCOBACTERIUM-TUBERCULOSIS; BIOLOGICAL EVALUATION; AGENTS; RESISTANCE; BIOFILMS; ANTIBACTERIAL; DERIVATIVES; MECHANISMS; INHIBITORS; DIVERSITY;
D O I
10.1039/c4ob02277g
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
2-Styryl quinolines (9a-l) have been synthesized regioselectively from 2-methyl-quinoline by using NaOAc in water acetic acid binary solvents and evaluated for their antibacterial activity against both Gram-positive and Gram-negative strains. Among these, the compounds 12 and 8 were found to be active against both bacterial strains. Compounds 9b, 9f, 9g, 9i, 9j and 9k were the most active among the series exhibiting MIC values ranging between 1.9 and 31.2 mu g ml(-1) against different bacterial strains. Compounds 9j and 9k were found to be as potent as the standard drug ciprofloxacin against Micrococcus luteus, Klebsiella planticola and Staphylococcus aureus. In addition, the compounds showed bactericidal activity; compound 9j was found to be better than ciprofloxacin, with an MBC value of 0.9 mu g ml(-1) against both M. luteus and K. planticola. The compounds also inhibited biofilm formation, and compound 9j was found to be equipotent to erythromycin against M. luteus and S. aureus MLS16. Further, theoretical studies such as those on druggable properties and PMI plot have been carried out.
引用
收藏
页码:1347 / 1357
页数:11
相关论文
共 47 条
[1]   Novel antibacterial agents for the treatment of serious Gram-positive infections [J].
Abbanat, D ;
Macielag, M ;
Bush, K .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (03) :379-399
[2]   A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis [J].
Andries, K ;
Verhasselt, P ;
Guillemont, J ;
Göhlmann, HWH ;
Neefs, JM ;
Winkler, H ;
Van Gestel, J ;
Timmerman, P ;
Zhu, M ;
Lee, E ;
Williams, P ;
de Chaffoy, D ;
Huitric, E ;
Hoffner, S ;
Cambau, E ;
Truffot-Pernot, C ;
Lounis, N ;
Jarlier, V .
SCIENCE, 2005, 307 (5707) :223-227
[3]  
[Anonymous], 5 NCCLS
[4]  
[Anonymous], 2008, SYBYL 8 0
[5]  
[Anonymous], 1997, SHELXL 97 SHELXS 97
[6]  
[Anonymous], 2001, SMART SAINT SOFTW RE
[7]  
Baltimore D. M., 1996, ANTIBIOTICS LAB MED, P52
[8]   Recent Advances in the Inhibition of Bacterial Type II Topoisomerases [J].
Bisacchi, Gregory S. ;
Dumas, Jacques .
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 44, 2009, 44 :379-396
[9]   The Calgary Biofilm Device: New technology for rapid determination of antibiotic susceptibilities of bacterial biofilms [J].
Ceri, H ;
Olson, ME ;
Stremick, C ;
Read, RR ;
Morck, D ;
Buret, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (06) :1771-1776
[10]  
Chervenkov S. K., 1995, ANAL LETT, V28, P57